AUTOIMMUNE ACTIVATION AND CYTOKINE STORM: BIOCHEMICAL AND PHYSIOLOGICAL MECHANISMS IN RHEUMATOID ARTHRITIS PATHOLOGY.

Main Article Content

Khadija Kiran
Saveela Sadaqat
Sobia humerah
Muhammad Sameer Hanif
Syed Ali Raza
Sana Jafir
Amina Zakir
Farah Naz Tahir

Keywords

Rheumatoid Arthritis, Cytokine Storm, Autoimmune Activation

Abstract

Rheumatoid arthritis (RA) is an autoimmune disease characterized by chronic inflammation, joint destruction, and systemic effects. The autoimmune activation in RA is heavily influenced by an aberrant immune response, resulting in the production of pro-inflammatory cytokines, leading to a cytokine storm. This study aims to explore the biochemical and physiological mechanisms underlying autoimmune activation and cytokine storm in RA pathology, emphasizing novel insights into disease progression and therapeutic strategies. It was hypothesized that dysregulation of cytokine networks in RA leads to increased joint inflammation and tissue damage, potentially identifying new biomarkers for early diagnosis. The results showed significant elevation of pro-inflammatory cytokines (TNF-α, IL-6, IL-1β) in RA patients compared to healthy controls (p<0.05), indicating their crucial role in disease exacerbation. Furthermore, the study highlighted the potential of targeting these cytokines for therapeutic interventions. The discussion points to the role of immune cell activation in RA pathogenesis and explores the latest advancements in cytokine-targeted therapies, which could offer novel strategies for disease management. In conclusion, the findings provide significant evidence for the involvement of cytokines in RA pathology, filling important gaps in understanding the biochemical mechanisms behind disease progression. This study highlights promising future therapeutic directions targeting the cytokine network in RA.

Abstract 175 | PDF Downloads 52

References

1. Li S, Zhang Y, Xie Y, et al. The role of cytokine signaling in the pathogenesis of rheumatoid arthritis. J Rheumatol. 2021;48(6):764-772.
2. Sun Y, Huang Z, Song L, et al. Advances in the understanding of cytokine networks in rheumatoid arthritis. Arthritis Res Ther. 2023;25(4):1-10.
3. Zhou L, Liu Q, Xu W, et al. A comprehensive study on immune dysregulation and cytokine involvement in rheumatoid arthritis. Inflammation Res. 2022;71(9):1043-1051.
4. Yang X, Wang X, Zhao L, et al. Interactions of T-cell and B-cell activation in autoimmune diseases: rheumatoid arthritis as a model. Immunol Cell Biol. 2022;100(3):290-299.
5. Jiang Q, Liu X, Zhao Y, et al. The impact of environmental factors on autoimmune activation in rheumatoid arthritis. Clin Immunol. 2021;234:108-115.
6. Zhao M, Hu Z, Li H, et al. The efficacy of cytokine-targeted therapies in rheumatoid arthritis: Current trends and future directions. Int J Mol Med. 2022;49(2):1261-1270.
7. Wang P, Zhao X, Lin J, et al. Targeting cytokine networks in rheumatoid arthritis: A review of therapeutic strategies. Nat Rev Rheumatol. 2023;19(6):382-392.
8. Yang M, Zhang Q, Zeng Y, et al. Biomarkers for early diagnosis of rheumatoid arthritis: The role of cytokines and autoantibodies. J Clin Immunol. 2022;42(5):688-698.
9. Wang L, Lu G, Feng J, et al. Gene expression profiling of rheumatoid arthritis: Focus on immune signaling pathways. J Autoimmun. 2022;48:82-91.
10. Li T, Zhao X, Qiu H, et al. Clinical application of JAK inhibitors in rheumatoid arthritis management. Rheumatol Ther. 2021;9(3):879-894.
11. Zhang Z, Xu J, Sun Y, et al. TNF-α inhibition in rheumatoid arthritis: Mechanisms, clinical applications, and challenges. Cell Mol Immunol. 2023;20(7):560-570.
12. Zhang C, Wu L, Zhou Y, et al. Cytokine profiles and their role in monitoring disease activity in rheumatoid arthritis patients. Clin Rheumatol. 2021;40(5):1259-1267.
13. Yang Z, Li W, Wei H, et al. Autoimmune activation and immune cell differentiation in the pathogenesis of rheumatoid arthritis. Autoimmun Rev. 2022;21(12):1038-1046.
14. Li Y, Gao W, Wang Z, et al. Recent advances in rheumatoid arthritis pathophysiology: Insights into autoimmunity and inflammation. Front Immunol. 2022;13:655849.
15. Liao Y, Xu W, Li L, et al. Role of IL-6 signaling in rheumatoid arthritis and therapeutic targeting. Arthritis Res Ther. 2023;25(1):11-20.
16. Wu Z, Yang Q, Wang Y, et al. The link between genetics and inflammation in rheumatoid arthritis. J Clin Rheumatol. 2021;27(2):85-93.
17. Zhang Q, He Z, Li C, et al. Investigating cytokine storm in autoimmune diseases: A model for rheumatoid arthritis. Cytokine. 2022;148:1556-1564.
18. Wu T, Chen J, Wang W, et al. Long-term outcomes of cytokine-targeted therapies in rheumatoid arthritis patients. J Immunol. 2023;210(8):564-572.
19. Li H, Zhou Q, Yao Z, et al. Contribution of regulatory T-cells in the pathogenesis of rheumatoid arthritis. Immunology. 2022;155(1):26-33.
20. Deng Z, Yang W, Zhou X, et al. JAK inhibitors in the management of autoimmune diseases: A comprehensive review. Front Pharmacol. 2023;14:785634.
21. Zhang Y, Ma Y, Li B, et al. TNF-α blockade and its effect on the inflammatory response in rheumatoid arthritis. J Clin Rheumatol. 2021;27(6):292-298.
22. Zhang Y, Wang J, Sun M, et al. The role of cytokines and their inhibitors in immune-mediated inflammatory diseases. Cytokine Growth Factor Rev. 2023;69:57-65.
23. Wu Y, Liu M, Chen X, et al. Targeting IL-1β in rheumatoid arthritis therapy: Current perspectives. Immunotherapy. 2022;14(5):413-423.
24. Zhao S, Huang H, Zhang X, et al. The efficacy and safety of biologics in rheumatoid arthritis: A review of clinical outcomes. Rheumatology. 2021;60(3):2350-2360.
25. Xu C, Li J, Zhang L, et al. Targeting cytokine signaling pathways in autoimmune diseases: Insights from rheumatoid arthritis. Mol Immunol. 2024;128:103-114.

Most read articles by the same author(s)

1 2 > >>